Rejuvenating the Livers of Mice Prevents Cancer Development

Experiment on Liver Rejuvenation

According to НВ — Техно: A study involving the rejuvenation of livers in aged mice through microbiome transplantation has produced encouraging results. Presented at the Digestive Disease Week (DDW) 2026 conference, researchers found that treated animals developed no cases of liver cancer, whereas tumors appeared in 2 out of 8 individuals in the control group. This suggests that restoring a youthful gut microbiome may slow liver aging and suppress tumor formation in older mice.

Research Methodology

In the experiment, titled 'Restoring a Young Gut Microbiome Slows Liver Aging and Suppresses Tumorigenesis in Aged Mice,' scientists collected fecal samples from eight young, healthy mice. These samples were frozen and then administered to older mice via fecal microbiota transplantation (FMT). A separate group of young rodents was used to compare molecular markers.

The study revealed that levels of the MDM2 protein, which is linked to cancer, were minimal in young mice. In untreated older mice, these levels were high, but they dropped sharply in the treated older mice.

This work clearly demonstrates that the aging microbiome is not just a passive reflection of the body's decline but actively drives liver dysfunction and accelerates cancer risks.

Qingjie Li, Associate Professor in the Division of Gastroenterology and Hepatology at the University of Texas Medical Center

These findings open new avenues for understanding the microbiome's role in aging and liver disease development, while underscoring the need for further research in this area. Notably, the results could inform new therapeutic strategies aimed at slowing aging and reducing cancer risk, which is especially relevant given the aging population and rising rates of liver disease in humans. This study may lay the groundwork for future clinical trials in people, potentially transforming approaches to liver disease treatment and prevention.

As researchers delve deeper into the complexities of aging and disease, understanding how age influences cancer progression becomes increasingly critical. Recent findings on the impact of age on melanoma spread highlight the intricate relationship between biological age and cancer outcomes. To explore this further, you can read about how age affects melanoma dissemination and its implications for treatment strategies.